Citation Impact
Citing Papers
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
The role of tacrolimus in adult kidney transplantation: a review
1998
LONG-TERM SURVIVAL OF DONOR-SPECIFIC PANCREATIC ISLET XENOGRAFTS IN FULLY XENOGENEIC CHIMERAS (WF RAT-B10 MOUSE) 1, 2
1992
Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up
2004
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
2016 StandoutNobel
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
2000 Standout
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
2007 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Neurotoxicity of calcineurin inhibitors: impact and clinical management
2000
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
2005
Right lobe living donor liver transplantation: A review
2000
Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: A case report
2001
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
2018
Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials
2006
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
2010 Standout
The utility of marginal donors in liver transplantation
2003
SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
1999 Standout
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation
2005
Recurrent disease in renal transplants
2003
Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future
2000
Cytoprotection of pancreatic islets before and early after transplantation using gene therapy
2002
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
NEW DRUGS TO IMPROVE TRANSPLANT OUTCOMES
2004
Vascular disorders of the liver # †
2008 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Type 2 diabetes as an inflammatory disease
2011 Standout
ESTABLISHMENT OF STABLE MULTILINEAGE HEMATOPOIETIC CHIMERISM AND DONOR-SPECIFIC TOLERANCE WITHOUT IRRADIATION1
2000
Management of Hepatocellular Carcinoma *
2005 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
A Risk-Benefit Assessment of Tacrolimus in Transplantation
1995
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
2007 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Diabetes Mellitus after Kidney Transplantation in the United States
2003 Standout
Utilization of Extended Donor Criteria Liver Allografts Maximizes Donor Use and Patient Access to Liver Transplantation
2005
Therapeutic apheresis in renal and metabolic diseases
2000
Nocardiosis at the Turn of the Century
2009 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
One-Year Results with Extended-Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
2007
Urinary tract infections after renal transplantation
2002
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Islet Transplantation at Subcutaneous and Intramuscular Sites
2005
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
2006 Standout
Immunosuppressive drugs: the first 50 years and a glance forward
2000
Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.
1994
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement
1990
PRIMARY IMMUNOSUPPRESSION WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL FOR RENAL ALLOGRAFT RECIPIENTS1
1998
Factors affecting the patency of arteriovenous fistulas for dialysis access
2011 StandoutNobel
Tacrolimus
1997
Mycophenolate mofetil and its mechanisms of action
2000 Standout
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
2010 Standout
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysis
2004
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Clinical application of sirolimus in renal transplantation: an update
2005
INCREASED INCIDENCE OF INSULIN-DEPENDENT DIABETES MELLITUS IN PEDIATRIC RENAL TRANSPLANT PATIENTS RECEIVING TACROLIMUS (FK506)
1998
MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION
2000
Tacrolimus-Related Microangiopathy in Kidney and Simultaneous Pancreas–Kidney Recipients: Evidence of Endothelin and Cytokine Involvement
1998
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 Standout
Islet Transplantation: Alternative Sites
2010
Early expansion of donor-specific Tregs in tolerant kidney transplant recipients
2018
Serial Ten‐Year Follow‐Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure
2005
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study
2005
Development of gene transfer for induction of antigen-specific tolerance
2014
Requirements and Challenges of a Preclinical Autoimmune Hepatitis Mouse Model
2011
SAFETY AND EFFICACY OF TACROLIMUS IN COMBINATION WITH MYCOPHENOLATE MOFETIL (MMF) IN CADAVERIC RENAL TRANSPLANT RECIPIENTS1
2000
Long-term Functioning of Allogeneic Islets in Subcutaneous Tissue Pretreated With a Novel Cyclic Peptide Without Immunosuppressive Medication
2017 StandoutNobel
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Prediabetes: a high-risk state for diabetes development
2012 Standout
A PROSPECTIVE, RANDOMIZED TRIAL OF TACROLIMUS/PREDNISONE VERSUS TACROLIMUS/PREDNISONE/MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS*
1999
Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine1
2002
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
2000 Standout
Transient increase of activated regulatory T cells early after kidney transplantation
2019
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism.
2002 StandoutNobel
Extended-Donor Criteria Liver Allografts
2006
PEDIATRIC RENAL TRANSPLANTATION UNDER TACROLIMUS-BASED IMMUNOSUPPRESSION1
1999
OUTCOME OF SUBCUTANEOUS ISLET TRANSPLANTATION IMPROVED BY POLYMER DEVICE1
1996
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Structural and functional changes resulting from islet isolation lead to islet cell death
1999
EFFECT OF HEPARIN ON THE PATENCY OF ARTERIOVENOUS FISTULA
2008
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
2009 Standout
Infections in solid-organ transplant recipients
1997
Posttransplantation Diabetes
2002
Tacrolimus
2000
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
2006
The Pathophysiological Significance of Nondesmoglein Targets of Pemphigus Autoimmunity
1998 Standout
Automated Method for Isolation of Human Pancreatic Islets
1988
Drug Therapy in the Heart Transplant Recipient
2005
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Aspergillus fumigatusand Aspergillosis
1999 Standout
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
1992 StandoutScience
Evaluation of potential liver donors: Limits imposed by donor variables in liver transplantation
2003
Hepatitis C and liver transplantation
2001
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Hematological Problems in Pediatric Intensive Care
2013 Standout
Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol
2001 Standout
Works of J. Miller being referenced
Expanded liver donor age over 60 years for hepatic transplantation
1997
Use of Tacrolimus and Mycophenolate Mofetil For Pancreas–Kidney Transplantation With or Without OKT3 Induction
1998
Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection
2002
Management of portal vein thrombosis in liver transplantation
1997
Use of Intravenous Tacrolimus to Reverse Vascular Rejection in Kidney and Simultaneous Kidney-Pancreas Transplantation
1998
Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving prograf and cellcept in combination therapy
1997
Removal of preformed cytotoxic antibody using PROSOR (staph protein-a-silica) column without immunosuppression
1997
IN SITU ENZYMATIC OLIGONUCLEOTIDE AMPLIFICATION OF HEPATITIS C VIRUS-RNA IN LIVER BIOPSY SPECIMENS (REVERSE TRANSCRIPTASE IN SITU POLYMERASE CHAIN REACTION) AFTER ORTHOTOPIC LIVER TRANSPLANTATION FOR HEPATITIS C-RELATED LIVER DISEASE
1998
The Impact of Campath 1H Induction in Adult Liver Allotransplantation
2005
Evidence for Microchimerism in Peripheral Blood, Bone Marrow, and Skin Following Donor Bone Marrow/Kidney–Pancreas Transplantation at 3 Years
1998
FK 506 in kidney transplantation: Results of the U.S.A. randomized comparative phase III study
1997
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression
2001
Evolving Approaches of Hematopoietic Stem Cell–Based Therapies to Induce Tolerance to Organ Transplants: The Long Road to Tolerance
2012
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial
1999
IgG Antibodies from Patients with Bullous Pemphigoid Bind to Fusion Proteins Encoded by BPAg1 cDNA
1993
FK 506 in simultaneous pancreas/kidney transplantation: The University of Miami experience
1997
Vascular complications, treatment, and outcome following orthotopic liver transplantation
1997
Cholesterol Control: Long-Term Benefit of Pancreas-Kidney Transplantation With FK 506 Immunosuppression
1998
Genitourinary Tuberculosis after Renal Transplantation: Report of 3 Cases and Review
2001
Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers
2015
Cytokine changes in thrombotic thrombocytopenic purpura following kidney transplantation
1993
Comparison of Tacrolimus With Neoral as Primary Immunosuppression in Hepatitis C Patients After Liver Transplantation
1998
Rapidly progressive focal segmental glomerulosclerosis occurring in a living related kidney transplant donor: case report and review of 21 cases of kidney transplants for primary FSGS.
1993
Islet cell transplantation in type I diabetes mellitus.
1987
Kidney transplantation at the University of Miami.
1999
DACLIZUMAB INDUCTION FOR PRIMARY KIDNEY TRANSPLANT RECIPIENTS USING TACROLIMUS, MYCOPHENOLATE MOFETIL AND STEROIDS AS MAINTENANCE IMMUNOSUPPRESSION.
1999
Natural history of intrahepatic canine islet cell autografts.
1986
Vascular complications following bladder drained, simultaneous pancreas-kidney transplantation: the University of Miami experience
2000
Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation.
1995
Renal transplantation in a new immunosuppressive era.
1995